EMERGING ANTIMICROBIALS AND DIAGNOSTICS in AMR: 26/27 NOV 2024

AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


2 February 2020

Using Machine Learning Techniques to Aid Empirical Antibiotic Therapy Decisions in the Intensive Care Unit of a General Hospital in Greece
30 January 2020

A rapid, non-invasive, cost-effective, analytical device for bacterial or viral infection diagnosis through ultra-high sensitivity breath analysis
30 January 2020

Incentivising antibiotic research and development: is the UK’s subscription payment model part of the solution?
30 January 2020

Radical change is required to ensure an antibiotic future
29 January 2020

Battling antibiotic resistance: new strategy targets bacterial slime
29 January 2020

A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance
29 January 2020

Race for new antibiotics: future success is hanging by a thread
29 January 2020

AMR: IMI’s Enable project reaches endpoints
29 January 2020

Can we make the antibiotic market great again?
28 January 2020

WILL ANTIBIOTIC INDUSTRY RISE UP TO THE CHALLENGE OF TACKLING GROWING ANTIBIOTIC RESISTANCE?
28 January 2020

Tackling antimicrobial resistance on multiple fronts
24 January 2020

New initiative seeks investors’ help to tackle antimicrobial resistance
24 January 2020

Diagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs
24 January 2020

Next important phase in infectious diseases research in Liverpool launched
23 January 2020

Only a few drugmakers even try to fight superbugs — a growing threat
22 January 2020

Tests Achieve 100% Concordance on Superbugs
22 January 2020

Imperial team win €22.5m EU funding to develop rapid test for serious illnesses
21 January 2020

Signs of progress against the superbugs, but not yet at the scale needed
19 January 2020

The AMR crisis is solvable — but we must act together and fast
18 January 2020

Lack of new antibiotics threatens global efforts to contain drug-resistant infections
18 January 2020

Fight against antibiotic crisis stymied by lack of R&D spend
17 January 2020

A faster way to determine antimicrobial susceptibility
17 January 2020

Probiotic Drink that Tackles Antibiotic Resistance Ousts Plasmids from Gut Bacteria
16 January 2020

Research: new breakthrough in battling resistance to antibiotics
16 January 2020

Antibacterial agents agent in preclinical development
16 January 2020

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs
16 January 2020

Wockhardt share price gains 14% on DCGI approval for 2 new antibiotics
15 January 2020

Inhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy
15 January 2020

New strategy in the fight against antibiotic resistance
15 January 2020

Effect of tolerance on the evolution of antibiotic resistance under drug combinations
14 January 2020

VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning
14 January 2020

CARB-X funds Trellis Bioscience to support the development of a monoclonal antibody designed to disrupt superbugs’ protective coating so that antibiotics can kill them
11 January 2020

2020 Antimicrobial Resistance Benchmark launches on 21 January
10 January 2020

Fusion Genomics Receives $1 Million Award to Evaluate Novel Genomic Diagnostics Platform in Collaboration with Sunnybrook Research Institute
9 January 2020

The skyrocketting need for speed: partnering to develop rapid diagnostic tests that protect patients from antibiotic resistant infections during disasters and every day
9 January 2020

Phase Genomics Receives $1.5MM NIH Grant to Develop Fast and Affordable Commercial Antimicrobial Resistance Tracking Kit
9 January 2020

CARB-X funds TAXIS PHARMACEUTICALS to accelerate development of innovative efflux pump inhibitors (EPIS), a new drug class that would impair bacteria’s ability to fight antibiotics
8 January 2020

Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking
8 January 2020

CARB-X backs Centauri to advance a new platform that combines antibiotic power with the ability to boost the immune system to fight infections caused by drug-resistant bacteria
8 January 2020

Antibiotics need a special place in the drug pricing debate
7 January 2020

GARDP developments
7 January 2020

Innovation Exchange to tackle NHS challenges around antimicrobial resistance
7 January 2020

Novo Holdings REPAIR Impact Fund invests USD12m in Mutabilis and IBT Vaccines
6 January 2020

The ‘broken’ antimicrobial market: A ‘looming cloud’ over medicine
6 January 2020

Antibiotics maker Melinta files for Chapter 11 bankruptcy
6 January 2020

Antibiotic Makers Struggle, Hurting War on Superbugs
4 January 2020

Why cloud-based data collaboration tech could defend against superbug outbreaks
4 January 2020

Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)
3 January 2020

Antabio Awarded $4.4 Million from CARB-X for the Further Development of its New Treatment for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients
2 January 2020

Winners of Hacking AMR 2019


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed